are glp-1 agonists safe America's Poison Centers GLP1 receptor agonists are supported
Description
GLP-1 agonist weight loss medications like Wegovy and Saxenda have a high probability of causing thyroid cancer based on available evidence These medications were originally designed for diabetes and then repurposed for weight loss, which means the long-term thyroid safety data is still limited The potential benefits of GLP-1 agonists for weight loss must be carefully weighed against the significant risk of developing thyroid cancer If you're considering these medications, have a detailed conversation with your doctor about your personal thyroid cancer risk versus the weight loss benefits Do the most popular weight loss medications of our time like Wegovy and Saxenda cause thyroid cancer
Heres a glimpse of our latest GLP-1 trend data discover how you can access the full dataset here
Demand for such drugs is likely to continue to be strong in the future due to rising rates of obesity and interlinked chronic diseases
Growth is supported by advances in oral peptide absorption technologies and increasing patient preference for needle free therapies
Left untreated, hepatic steatosis advances to steatohepatitis, then to fibrosis, and eventually to cirrhosis
Myths & facts: GLP-1 drugs for weight loss
